Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Retrovirus
Researchers from Food & Drug Administration detail new studies and findings in the area of retrovirus
July 7th, 2009
"PCR-based reverse transcriptase (RT) assays are highly sensitive for broad detection of retroviruses. These are Currently used for demonstrating the absence of retroviral contamination in vaccines and can also be applied to clinical and laboratory research to investigate low-virus replication," investigators in the United States report. "A single-tube fluorescent product-enhanced reverse transcriptase assay (STF-PERT) has been published that was highly sensitive for retrovirus detection (<10 virions), with enhanced reproducibility and increased efficiency [Sears, J.F., Khan, A.S., 2003. Single-tube fluorescent product-enhanced reverse transcriptase assay with...
Source: Cancer Weekly (2009-07-07)
|
